Royalty Pharma plc Announces Completion of $2 Billion Senior Notes Offering

Royalty Pharma plc has successfully completed its offering of $2 billion in senior unsecured notes, consisting of $600 million in 4.450% Senior Notes due 2031, $900 million in 5.200% Senior Notes due 2035, and $500 million in 5.950% Senior Notes due 2055. The notes were issued under an indenture dated September 2, 2020, and are guaranteed by Royalty Pharma Holdings Ltd and Royalty Pharma Manager, LLC. The proceeds from the offering will be used for general corporate purposes. The offering was underwritten by a syndicate of banks led by BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and TD Securities (USA) LLC. The notes were issued pursuant to a registration statement filed with the SEC and are listed on the Nasdaq Stock Market.